stockrowEnsysce Biosciences, Inc. (ENSC) vs Alaunos Therapeutics, Inc. (TCRT)
- Ensysce Biosciences, Inc. ENSC 0.34 −5.56%
- Alaunos Therapeutics, Inc. TCRT 1.80 −2.17%
Ensysce Biosciences, Inc. and Alaunos Therapeutics, Inc. are both Biotechnology companies. Ensysce Biosciences, Inc. and Alaunos Therapeutics, Inc. are of similar size ($7.6M and $7.0M). Alaunos Therapeutics, Inc. grew revenue faster over the last twelve months: −17.7% against −39.3%. Alaunos Therapeutics, Inc. has the higher net margin (0.00% vs −280.5%) and the lower return on invested capital (−480.4% vs 0.00%). Across the 15 metrics below, Alaunos Therapeutics, Inc. leads on 10 and Ensysce Biosciences, Inc. on 5.
Valuation
Profitability
| Metric | ENSC | TCRT | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 68.51% |
| Operating margin | (281.32%) | 0.00% | 0.00% |
| Net margin | (280.49%) | 0.00% | 0.00% |
| Free cash flow margin | (196.76%) | 0.00% | 0.00% |
| Return on equity | (1,295.01%) | (185.95%) | (51.96%) |
| Return on assets | (295.92%) | (128.30%) | (46.06%) |
| Return on invested capital | 0.00% | (480.35%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack